Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

SUMMARY: Bone mineral density (BMD) sometimes cannot be improved by long-term bisphosphonate (BP) therapy in osteoporosis (OP). This study showed that lumbar as well as hip BMD significantly increased after denosumab treatment in patients not responsive to BPs. Thus, denosumab may be a strong OP tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimura, M., Nakamura, Y., Ikegami, S., Uchiyama, S., Kato, H., Taguchi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269470/
https://www.ncbi.nlm.nih.gov/pubmed/27650642
http://dx.doi.org/10.1007/s00198-016-3764-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269470/
https://www.ncbi.nlm.nih.gov/pubmed/27650642
http://dx.doi.org/10.1007/s00198-016-3764-7

Ejemplares similares